DMC Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
DMC Group's NVO Position: Q2 2026 in Review
DMC Group reduced its Novo Nordisk (NVO) stake by 27% in Q2 2026, selling an estimated $112K and leaving 7,155 shares worth $343K. The position accounts for 0.24% of the portfolio, ranked #104.
DMC Group first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.79M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- DMC Group held 7,155 shares of Novo Nordisk worth $343K as of Q2 2026.
- DMC Group sold 2,599 Novo Nordisk shares in Q2 2026, an estimated $112K.
- Novo Nordisk made up 0.24% of DMC Group's portfolio in Q2 2026, its #104 holding.
- DMC Group first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
- DMC Group's Novo Nordisk position peaked at $1.79M in Q2 2024.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on DMC Group's 13F filing for Q2 2026, filed 28 Jul 2026.